0001193805-23-001069.txt : 20230803 0001193805-23-001069.hdr.sgml : 20230803 20230803160932 ACCESSION NUMBER: 0001193805-23-001069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230801 FILED AS OF DATE: 20230803 DATE AS OF CHANGE: 20230803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marquet Magda CENTRAL INDEX KEY: 0001631486 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38942 FILM NUMBER: 231140002 MAIL ADDRESS: STREET 1: ALTHEADX INC. STREET 2: 3550 DUNHILL STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcturus Therapeutics Holdings Inc. CENTRAL INDEX KEY: 0001768224 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8589002660 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 e618807_4-marquet.xml X0508 4 2023-08-01 0 0001768224 Arcturus Therapeutics Holdings Inc. ARCT 0001631486 Marquet Magda C/O ARCTURUS THERAPEUTICS HOLDINGS INC. 10628 SCIENCE CENTER DRIVE, SUITE 250 SAN DIEGO CA 92121 1 0 0 0 0 Stock option (right to buy) 34.92 2023-08-01 4 A 0 11869 0.00 A 2033-08-01 Common Stock 11869 11869 D Deferred Stock Units 2023-08-01 4 A 0 3131 0.00 A Common Stock 3131 3131 D Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Each deferred stock unit is economically equivalent to one share of the Issuer's common stock Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. /s/ Ilan Katz, attorney-in-fact 2023-08-03